Cargando…

Utilizing CD30 expression as a rational target for therapy of lymphoma

Detalles Bibliográficos
Autor principal: Kim, Won Seog
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337265/
http://dx.doi.org/10.1186/1756-8722-5-S1-A2
_version_ 1782231052751732736
author Kim, Won Seog
author_facet Kim, Won Seog
author_sort Kim, Won Seog
collection PubMed
description
format Online
Article
Text
id pubmed-3337265
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33372652012-04-26 Utilizing CD30 expression as a rational target for therapy of lymphoma Kim, Won Seog J Hematol Oncol Meeting Abstract BioMed Central 2012-04-25 /pmc/articles/PMC3337265/ http://dx.doi.org/10.1186/1756-8722-5-S1-A2 Text en Copyright ©2012 Kim; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Abstract
Kim, Won Seog
Utilizing CD30 expression as a rational target for therapy of lymphoma
title Utilizing CD30 expression as a rational target for therapy of lymphoma
title_full Utilizing CD30 expression as a rational target for therapy of lymphoma
title_fullStr Utilizing CD30 expression as a rational target for therapy of lymphoma
title_full_unstemmed Utilizing CD30 expression as a rational target for therapy of lymphoma
title_short Utilizing CD30 expression as a rational target for therapy of lymphoma
title_sort utilizing cd30 expression as a rational target for therapy of lymphoma
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337265/
http://dx.doi.org/10.1186/1756-8722-5-S1-A2
work_keys_str_mv AT kimwonseog utilizingcd30expressionasarationaltargetfortherapyoflymphoma